Skip to content
OpenCapital
Get started

ADMA Biologics ADMA Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

Zymeworks logo
ZymeworksZYME
$36K+100%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$65.32M+123%
Amgen logo
AmgenAMGN
——
Haemonetics logo
HaemoneticsHAE
——
Gilead Sciences logo
Gilead SciencesGILD
——

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.02B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's increase (decrease) in accounts receivable?
ADMA Biologics (ADMA) reported increase (decrease) in accounts receivable of -$22.57M in Q1 2026.
How has ADMA Biologics's increase (decrease) in accounts receivable changed year-over-year?
ADMA Biologics's increase (decrease) in accounts receivable decreased by 145.7% year-over-year, from $49.41M to -$22.57M.
What does increase (decrease) in accounts receivable mean?
Represents the net change in the amount owed to the company by customers for goods or services delivered on credit. An increase indicates that revenue growth is outpacing cash collections, which may signal potential liquidity pressure or changes in customer payment behavior.